Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit regarding its MAGicBead cfDNA isolation technology filed by Qiagen GmbH in the United States District Court for the Central District of California on August 20, 2024. Zymo Research respects intellectual property rights and believes that this technology represents a major advancement in nucleic acid purification.
“Our MAGic cfDNA purification system is a breakthrough innovation,” said Dr. Larry Zia, founder and CEO of Zymo Research. “While this legal action places a significant strain on our resources as a small company, our commitment to the scientific community is stronger than ever.”
With a philosophy of “scientists for scientists,” Zymo Research has been providing innovative solutions to meet the evolving needs of researchers for over 30 years. Despite being a small company with approximately 250 employees, Zymo Research offers cutting-edge solutions ranging from genetic, epigenetic and microbiomics research tools to environmentally friendly sample transport solutions, thanks to a culture that prioritizes innovation, quality and customer service.
“Our success is rooted in the trust of our customers and researchers around the world,” said Dr. Mark Van Eden, vice president of Corporate Development. “We are committed to serving our communities with the best and most innovative products.”
Despite this legal challenge, Zymo Research remains focused on its mission to advance the life sciences with reliable solutions trusted by thousands of researchers around the world, reminding us of its unwavering commitment to the betterment of science and humanity.
/cdn.vox-cdn.com/uploads/chorus_asset/file/25697397/STK071_APPLE_N.jpg?w=150&resize=150,150&ssl=1 "Apple is reportedly working on developing “LLM Siri” to compete with ChatGPT")
